छोड़कर सामग्री पर जाएँ

PharmEasy CEO hopes to return to market with an IPO if robust performance sustains

  • द्वारा
  • Latest News

The company is awaiting Competition Commission of India (CCI) approval for the rights issue.

Read More

​ The company is awaiting Competition Commission of India (CCI) approval for the rights issue. The company is awaiting Competition Commission of India (CCI) approval for the rights issue.  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी